亿胜生物科技（股票代码：01061）于6月22日发布公告，披露其在香港联交所场内回购股份。公司当日共回购股份71,000股，占前一交易日已发行股本约0.01252%，回购价格介乎每股2.62港元至2.64港元，总金额为186,440港元（折合约18.64万港元）。
公告显示，本次回购完成后，公司已发行股本（不包括库藏股）数目约为566,800,000股，库藏股数目增至206,000股。公司于2026年5月26日曾通过购回授权，可回购合计56,700,600股；目前在香港联交所或其他证券交易所已累计回购206,000股，占授权决议通过当日已发行股本的约0.03633%。公司同时确认，已遵守香港联交所《证券上市规则》及相关法律法规。公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.